ARA-290
ARA-290 (cibinetide) is an 11-residue peptide modeled on erythropoietin, studied at the innate repair receptor. Approved buyers can apply for wholesale access.
Bulk Peptides Co supplies ARA-290 at wholesale to approved business buyers in 10mg and 16mg vials, from overseas-sourced supply (typically 7-10 days). Every lot is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Pricing is quoted by supply option and tiered by volume.
Updated
- Synonyms
- Cibinetide, pHBSP, Pyroglutamate helix B surface peptide, ARA290
- Formula
- C51H84N16O21
- Molecular weight
- 1257.3 g/mol
- Sequence
- pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
- CAS number
- 1208243-50-8
Approved buyers see pricing
Wholesale pricing is available to approved business buyers after they log in.
Supply and testing
- Every lot third-party testedHPLC for purity, mass spectrometry for identity. Labs: Freedom Diagnostics and ILS Labs.
- Three supply optionsSupply options for wholesale ordersUSA stock (ships from US inventory), USA-synthesized, overseas-sourced.Ask which options apply to this compound.
- Same-day shipping on USA stockExpedited options available. Overseas-sourced orders typically take 7-10 days.
- No minimum on USA stockOne box to thousands of kits, plus gram and kilogram powder.
- COA in your company nameCan be added to an order and is provided with it.
Bulk ordersUSA and overseas supplyShipping times
Request a quote for ARA-290Cut from a larger protein
ARA-290, also called cibinetide or pHBSP (pyroglutamate helix B surface peptide), is an eleven-residue peptide. It was modeled on the three-dimensional structure of erythropoietin in the region of helix B, so it borrows one surface of a large protein hormone while leaving out the rest. Its N-terminal glutamine is cyclized to pyroglutamate, which is where the "pGlu" in the sequence and the "p" in pHBSP come from.
A receptor distinct from the one in red blood cells
The reason for the design is a receptor distinction. Reviewers explain that erythropoietin stimulates red-cell progenitors through an EPO receptor homodimer, whereas a heteromer of the EPO receptor and the beta common receptor (CD131), termed the innate repair receptor, is linked with tissue-protective signaling and is induced by injury or inflammation. ARA-290 was engineered to engage the second receptor without acting through the first. A 2015 review in Pharmacology & Therapeutics summarises its pharmacokinetics and the unusual finding that a peptide with a plasma half-life of only a couple of minutes was reported to produce effects lasting much longer in animal models, and notes that it has also been examined in clinical trials.
What the preclinical papers show
Two further papers explore different parts of the biology:
- Immune cells. A 2017 mouse study in dextran sulphate-induced colitis found that cibinetide, like erythropoietin, was associated with reduced myeloid cell infiltration and lower production of pro-inflammatory mediators in the gut tissue. Experiments in lipopolysaccharide-activated primary macrophages pointed to a direct effect on innate immune cell function.
- Sensory neurons. A 2016 study used calcium imaging, cultured cells and behavioral tests to show that ARA 290 inhibited TRPV1 channel activity and reduced capsaicin-induced mechanical hypersensitivity. The authors suggest it may act as an antagonist of this channel, a possibility that adds to the receptor-based explanation.
Both findings come from experimental systems, and neither shows what the peptide would do in people.
Sourcing notes
Peptides with an N-terminal pyroglutamate lack a free amino group, which affects some sequencing approaches, so identity is best confirmed by intact mass. Our storage and stability guide covers how lyophilized material should be handled once it arrives.
Supply is for approved business buyers, for laboratory research use only.
References
- Collino M, et al. Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. Pharmacol Ther. 2015.
- Nairz M, et al. Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis. Sci Rep. 2017.
- Zhang W, et al. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception. Peptides. 2016.
Questions
Where can I buy ARA-290 in bulk?
Bulk Peptides Co supplies ARA-290 to approved business buyers in 10mg and 16mg vials, from overseas-sourced supply (typically 7-10 days). Apply for a buyer account to see wholesale pricing; larger volumes are quoted on request.
How much does ARA-290 cost wholesale?
Bulk Peptides Co shows wholesale pricing for ARA-290 to approved business accounts after login. Pricing is quoted by supply option and tiered by volume, so the per-box price falls as the box count rises.
Is ARA-290 sold for use in humans?
No. Bulk Peptides Co sells ARA-290 to approved business buyers for laboratory research use only, not for use in humans.
Can I buy ARA-290 from a US supplier?
Bulk Peptides Co lists ARA-290 from overseas-sourced supply, which typically takes 7-10 days to arrive. Ask whether USA stock is available when you request a quote.
Is each lot of ARA-290 third-party tested?
Yes. Every lot Bulk Peptides Co supplies is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Lot COAs appear on this page as they are uploaded.
